PGP and cancer: For instance, co-delivery of DOX and siRNA against multidrug resistance (MDR) proteins, such as P-glycoprotein (P-gp), has been demonstrated to sensitize drug-resistant cancer cells to DOX treatment, hence overcoming drug resistance and improving overall therapeutic efficiency [303].